Home arrow Meldungen arrow Pressemitteilungen arrow CEM Receives Fourth Patent for Microwave Peptide Synthesis
Donnerstag, 2. Juli 2020
 
 
analytik.de
analytik.de - news
Foto des Monats
Bild des Monats
CEM Receives Fourth Patent for Microwave Peptide Synthesis

CEM, a leading global provider of microwave laboratory instrumentation, is pleased to announce that its fourth US patent covering microwave-assisted peptide synthesis (US 7,582,728) was issued on September 1, 2009. The patent contains broad claims regarding the process of using microwave energy to accelerate two key steps in performing almost all solid phase peptide synthesis, deprotection and coupling. In addition, the Company’s third patent (US 7,563,865) for microwave peptide synthesis was issued on July 21, 2009 and specifically covered the process of performing Fmoc and Boc chemistries, the two most common strategies employed in peptide synthesis.

“We are pleased to now have four patents covering microwave solid phase peptide synthesis,” commented Michael J. Collins, president & CEO of CEM Corporation. “The two most recent patents to issue are both process based and will provide broad coverage in using microwave energy to accelerate peptide synthesis. There are also a number of additional peptidepatent applications still pending, which should create an even stronger product portfolio for CEM in the future.”

Microwave technology has started to gain substantial acceptance in the peptide synthesis market. It is allowing research scientists in key industrial and academic centers around the world to make longer, more difficult peptides that were not possible to produce using conventional techniques. It is a faster technique that produces higher purity peptides and allows for the use of more simplified chemistries.

“Our Liberty™ System has become the best-selling peptidesynthesizer in a very short period of time and we have continued to achieve substantial growth in this area, even during the recent worldwide economic slowdown,” said Collins. “This represents an exciting growth opportunity for CEM and we remain strongly committed to supporting and expanding the market. It will continue to be an important focus of our R&D efforts, as the technology continues to evolve.”

Weitere Infos unter
www.peptid-synthese.de

Quelle: CEM GmbH

http://www.cem.de

 
 
  Top
LogIn